Rezolute (RZLT) Profit After Tax (2010 - 2026)
Rezolute recorded quarterly Profit After Tax of -$16.2 million in Q1 2026, up 28.99% quarter-over-quarter from -$22.8 million in Q4 2025, and up 14.5% year-over-year from -$14.1 million in Q1 2025.
Rezolute's Profit After Tax history runs 17 years deep, the most recent figure standing at -$16.2 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 14.5% year-over-year to -$16.2 million; the TTM figure through Mar 2026 stood at -$81.5 million (down 11.68% YoY), while the FY2025 annual figure was -$74.4 million, down 8.68% from the prior year.
- Profit After Tax came in at -$16.2 million for Q1 2026 at Rezolute, up from -$22.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$9.4 million in Q2 2022 to a low of -$24.4 million in Q2 2025.
- A 5-year average of -$16.0 million and a median of -$15.7 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax plunged 203.33% in 2022 and gained 14.5% in 2026, its largest moves.
- Rezolute's Profit After Tax stood at -$13.6 million in 2022, then slipped by 2.6% to -$13.9 million in 2023, then slipped by 13.09% to -$15.7 million in 2024, then sank by 44.78% to -$22.8 million in 2025, then climbed by 28.99% to -$16.2 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$16.2 million, -$22.8 million, and -$18.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | -16.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.17 Mn |
| Dec 31, 2025 | -22.77 Mn |
| Sep 30, 2025 | -18.20 Mn |
| Jun 30, 2025 | -24.38 Mn |
| Mar 31, 2025 | -18.91 Mn |
| Dec 31, 2024 | -15.73 Mn |
| Sep 30, 2024 | -15.38 Mn |
| Jun 30, 2024 | -22.98 Mn |
| Mar 31, 2024 | -17.05 Mn |
| Dec 31, 2023 | -13.91 Mn |
| Sep 30, 2023 | -14.52 Mn |
| Jun 30, 2023 | -12.73 Mn |
| Mar 31, 2023 | -15.67 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -9.42 Mn |
| Mar 31, 2022 | -11.21 Mn |
| Dec 31, 2021 | -12.59 Mn |
| Sep 30, 2021 | -7.84 Mn |
| Jun 30, 2021 | -6.49 Mn |
| Mar 31, 2021 | -3.70 Mn |
| Dec 31, 2020 | -7.10 Mn |
| Sep 30, 2020 | -3.62 Mn |
| Jun 30, 2020 | -3.55 Mn |
| Mar 31, 2020 | -5.04 Mn |
| Dec 31, 2019 | -6.67 Mn |
| Sep 30, 2019 | -5.08 Mn |
| Jun 30, 2019 | 57.70 Mn |
| Mar 31, 2019 | -19.77 Mn |
| Dec 31, 2018 | -4.16 Mn |
| Sep 30, 2018 | -3.37 Mn |
| Jun 30, 2018 | -12.49 Mn |
| Mar 31, 2018 | -4.97 Mn |
| Dec 31, 2017 | -5.72 Mn |
| Sep 30, 2017 | -6.68 Mn |
| Jun 30, 2017 | -6.19 Mn |
| Mar 31, 2017 | -5.38 Mn |
| Dec 31, 2016 | -4.89 Mn |
| Sep 30, 2016 | -3.82 Mn |
| Jun 30, 2016 | -3.87 Mn |
| Mar 31, 2016 | -3.71 Mn |
| Dec 31, 2015 | -4.07 Mn |
| Sep 30, 2015 | -3.29 Mn |
| Jun 30, 2015 | -3.04 Mn |
| Mar 31, 2015 | -3.17 Mn |
| Dec 31, 2014 | -2.94 Mn |
| Sep 30, 2014 | -2.21 Mn |
| Jun 30, 2014 | -2.01 Mn |
| Mar 31, 2014 | -5.09 Mn |
| Dec 31, 2013 | -1.82 Mn |
| Sep 30, 2013 | -819,531.00 |
| Jun 30, 2013 | -1.03 Mn |
| Mar 31, 2013 | -4.53 Mn |
| Dec 31, 2012 | -537,514.00 |
| Sep 30, 2012 | -630,850.00 |
| Jun 30, 2012 | -398,209.00 |
| Mar 31, 2012 | -176,870.00 |
| Dec 31, 2011 | -7,998.00 |
| Sep 30, 2011 | -7,394.00 |
| Mar 31, 2011 | -24,407.00 |
| Dec 31, 2010 | -1,751.00 |
| Sep 30, 2010 | -25,000.00 |